Ignite Creation Date:
2024-05-05 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00391716
Status:
COMPLETED
Last Update Posted:
2014-11-10
First Post:
2006-10-20
Brief Title:
Gabapentin Treatment of Alcohol Dependence
Sponsor:
The Scripps Research Institute
Organization:
The Scripps Research Institute
Study Overview
Official Title:
Gabapentin Treatment of Alcohol Dependence
Status:
COMPLETED
Status Verified Date:
2014-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Gabapentin treatment for alcohol dependence
Detailed Description:
This is a 12-week double blind placebo controlled dose ranging study to evaluate the efficacy of gabapentin in treating outpatients with alcohol dependence Subjects receive 900mg or 1800mg gabapentin or placebo daily for 12 weeks accompanied by weekly standardized counseling for alcohol-related behavior with assessments of alcohol consumption mood sleep and alcohol-craving performed each week
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R37AA014028 | NIH | None | httpsreporternihgovquickSearchR37AA014028 |